Sernova Biotherapeutics (XTER:PSH0) 6-Month Share Buyback Ratio : -8.19% (As of Jan. 2025 )

View and export this data going back to 2021. Start your Free Trial

What is Sernova Biotherapeutics 6-Month Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

6-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past six months, calculated as the percentage change in shares outstanding from two quarters ago to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Sernova Biotherapeutics's current 6-Month Share Buyback Ratio was -8.19%.

Competitive Comparison of Sernova Biotherapeutics's 6-Month Share Buyback Ratio

For the Biotechnology subindustry, Sernova Biotherapeutics's 6-Month Share Buyback Ratio, along with its competitors' market caps and 6-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova Biotherapeutics's 6-Month Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's 6-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's 6-Month Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Sernova Biotherapeutics 6-Month Share Buyback Ratio Calculation

Sernova Biotherapeutics's 6-Month Share Buyback Ratio for the quarter that ended in Jan. 2025 is calculated as

6-Month Share Buyback Ratio	=	(Shares Outstanding (EOP) (Jul. 2024 )	-	Shares Outstanding (EOP) (Jan. 2025 ))	/	Shares Outstanding (EOP) (Jul. 2024 )
	=	(303.613	-	328.485)	/	303.613
	=	-8.19%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics (XTER:PSH0) 6-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Sernova Biotherapeutics 6-Month Share Buyback Ratio Related Terms

Sernova Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (XTER:PSH0) » Definitions » 6-Month Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH0:Germany SVA:Canada

Address

700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Sernova Biotherapeutics Headlines

No Headlines